CDC warns that a parasitic illness called Chagas disease is now endemic — or always present — in several states. Biting insects called kissing bugs have been identified in 32 states, predominantly in ...

Oct 14 (Reuters) - BioCryst Pharmaceuticals (BCRX.O), opens new tab said on Tuesday it would buy Astria Therapeutics (ATXS.O), opens new tab in a cash-and-stock deal valued at about $700 million, ...

Heart disease continues to stand as the No. 1 cause of death in the United States. Coronary heart disease, the most common type of heart disease in the U.S., was responsible for the deaths of nearly ...

Global mortality rates are falling, but not among youths and young adults, according to the latest Global Burden of Disease (GBD) study published in The Lancet today and presented at the World Health ...

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...

Measles is not the only disease that has increased as the number of childhood vaccinations have decreased in South Carolina over the past several years. Cases of whooping cough and chicken pox have ...

In the journal Childhood in the Past, Ph.D. candidate Duru Yağmur Başaran published the results of an analysis of an over 900-year-old skeleton of a child. The study revealed that a 2.5 to ...

Millions of adults in their 20s or older have coronary artery disease. But experts say the common condition doesn’t have to be an inevitable part of aging. There are steps you can take to reduce your ...

Targeted indoor residual spraying focuses insecticide applications on common resting surfaces of Aedes aegypti mosquitoes (an arboviral disease vector) in houses, such as exposed lower sections of ...

Delphi-2M, a new generative artificial intelligence (AI) model, estimates an individual’s risk for more than 1000 diseases up to 20 years in advance by analyzing electronic health records and ...

The FDA has issued a manufacturing-related complete response letter for Cyprium Therapeutics’ copper histidinate drug candidate CUTX-101, raising a roadblock on the path to commercializing the first ...